Avanir Pharmaceuticals (NASDAQ:AVNR) was upgraded by Jefferson Research from a “sell” rating to a “hold” rating in a research note issued on Friday, StockRatingsNetwork reports. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock opened at $4.29 in last session, and closed at $5.00, while the day range of stock is $4.22 – $5.08. The stock showed a positive weekly performance of 16.55%.
Mylan Inc (NYSE:MYL) Insider Anthony Mauro sold 20,000 shares of the stock on the open market in a transaction dated Monday, March 3rd. The stock was sold at an average price of $54.81, for a total value of $1,096,200.00. Mylan Inc (NASDAQ:MYL) stock opened at $57.06, in last session and closed at $55.84, by losing -2.38%. The 52 week range of the stock is $27.66 – $57.52. Company’s market capitalization is $21.37 billion.
Zoetis Inc (NYSE:ZTS) has named a veterinarian considered a world leader in animal health to its board of directors. Zoetis Inc (NYSE:ZTS) stock decreased -0.55% and finished the last session at $30.72. The EPS of the stock remained 0.78. Company’s market capitalization is $15.36 billion.
Actavis plc (NYSE:ACT), a leading global specialty pharmaceutical company, announced that Paul Bisaro, Chairman and CEO of Actavis, will provide an overview and update of the Company’s business at the Barclays Global Healthcare Conference in Miami. Actavis plc Ordinary Shares (NYSE:ACT) stock opened the session at $227.06, and closed the session at $224.55. The 52 week range of the stock remained $85.81 – $230.77 and the day range was $223.73 – $227.39.
Leave a Reply